Author(s): Wojciech Fendler | Anna Hogendorf | Agnieszka Szadkowska | Wojciech Młynarski
Journal: Pediatric Endocrinology, Diabetes and Metabolism
ISSN 2081-237X
Volume: 17;
Issue: 2;
Start page: 57;
Date: 2011;
VIEW PDF
DOWNLOAD PDF
Original page
Keywords: blood glucose self-monitoring | type 1 diabetes | children | 0 |
ABSTRACT
Introduction: Self-monitoring of blood glucose (SMBG) is one of the cornerstones of diabetes management. Aim of the study: To evaluate the potential for miscoding of a personal glucometer, to define a target population among pediatric patients with diabetes for a non-coding glucometer and the accuracy of the Contour TS non-coding system. Material and methods: Potential for miscoding during self-monitoring of blood glucose was evaluated by means of an anonymous questionnaire, with worst and best case scenarios evaluated depending on the responses pattern. Testing of the Contour TS system was performed according to guidelines set by the national committee for clinical laboratory standards. Results: Estimated frequency of individuals prone to non-coding ranged from 68.21% (95% 60.70- 75.72%) to 7.95% (95%CI 3.86-12.31%) for the worse and best case scenarios respectively. Factors associated with increased likelihood of non-coding were: a smaller number of tests per day, a greater number of individuals involved in testing and self-testing by the patient with diabetes. The Contour TS device showed intra- and inter-assay accuracy ?95%, linear association with laboratory measurements (R2=0.99, p
Journal: Pediatric Endocrinology, Diabetes and Metabolism
ISSN 2081-237X
Volume: 17;
Issue: 2;
Start page: 57;
Date: 2011;
VIEW PDF


Keywords: blood glucose self-monitoring | type 1 diabetes | children | 0 |
ABSTRACT
Introduction: Self-monitoring of blood glucose (SMBG) is one of the cornerstones of diabetes management. Aim of the study: To evaluate the potential for miscoding of a personal glucometer, to define a target population among pediatric patients with diabetes for a non-coding glucometer and the accuracy of the Contour TS non-coding system. Material and methods: Potential for miscoding during self-monitoring of blood glucose was evaluated by means of an anonymous questionnaire, with worst and best case scenarios evaluated depending on the responses pattern. Testing of the Contour TS system was performed according to guidelines set by the national committee for clinical laboratory standards. Results: Estimated frequency of individuals prone to non-coding ranged from 68.21% (95% 60.70- 75.72%) to 7.95% (95%CI 3.86-12.31%) for the worse and best case scenarios respectively. Factors associated with increased likelihood of non-coding were: a smaller number of tests per day, a greater number of individuals involved in testing and self-testing by the patient with diabetes. The Contour TS device showed intra- and inter-assay accuracy ?95%, linear association with laboratory measurements (R2=0.99, p